insights_auto
Why is INO down 2,05%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43 $
arrow_downward
-2,05%(-0,030) 1D
1,42 $
arrow_downward
-0,70% (-0,0100)todayPre-market
Closed: 13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,44 $
High
1,48 $
Low
1,39 $
Mkt. cap
267,85 մլն
Avg. vol.
19,26 մլն
Volume
9,83 հզր
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
Open
1,44 $
High
1,48 $
Low
1,39 $
Mkt. cap
267,85 մլն
Avg. vol.
19,26 մլն
Volume
9,83 հզր
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
News stories
From web sources and news partners
MarketWatch
·
57 րոպե առաջ
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
Investing.com
·
47 րոպե առաջ
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
The Motley Fool
·
2 ժամ առաջ
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
3 րոպե առաջ
Billionaire Elon Musk's SpaceX eyes S&P 500 via Tesla deal
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc